SCHEMBL5224388

SCHEMBL5224388

COc1cc2[c]ccnc2cc1OCCCc1nc[nH]n1

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 5/20 0.33
▸ EHMT1 Q9H9B1 4/20 0.33
▸ HTR2A P28223 2/20 0.32
▸ PDGFRB P09619 1/20 0.31
▸ PDGFRA P16234 1/20 0.31
▸ ENPP1 P22413 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197798 0.79 PDGFRB (0.46) PDGFRBPDGFRA
SCHEMBL197931 0.78 EGFR (0.40) EHMT2EHMT1
SCHEMBL199314 0.74 EHMT2 (0.60) EHMT2EHMT1
SCHEMBL198154 0.74 KMT5A (0.43) EHMT2ENPP1
SCHEMBL199299 0.73 EHMT2 (0.51) EHMT2EHMT1
SCHEMBL197702 0.72 KDM4E (0.53) EHMT2EHMT1HSD17B10
SCHEMBL199128 0.71 AXL (0.52) EHMT2EHMT1
SCHEMBL197930 0.66 PDGFRB (0.33) PDGFRBPDGFRA
SCHEMBL16673289 0.62 L3MBTL1 (0.37) —
SCHEMBL16673303 0.62 L3MBTL1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827434-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER Amgen Inc. (US) 2007-09-05 — — EP disclosed
WO-2006060318-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER AMGEN INC. (US) 2006-06-08 — — WO disclosed
Send feedback